{"database": "lobbying", "table": "lobbying_activities", "rows": [[2152743, "b6646789-5c84-4ae7-a86a-ac7481daaff8", "Q2", "BUCHANAN INGERSOLL & ROONEY PC", 55291, "ANI PHARMACEUTICALS, INC.", 2018, "second_quarter", "PHA", "Federal government relations service, strategy development and implementation relating to status of FDAs action with regards to the companys NDA.", "Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2018-07-19T05:51:08.167000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2152743"], "units": {}, "query_ms": 0.3251300659030676, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}